Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Christopher Sinesi"'
Autor:
J. Isabelle Choi, Kiran Prabhu, William F. Hartsell, Todd DeWees, Christopher Sinesi, Carlos Vargas, Rashmi K. Benda, Oren Cahlon, Andrew L. Chang
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 71-77 (2022)
Purpose: Proton therapy (PT) for partial breast irradiation (PBI) in early-stage breast cancer can decrease morbidity versus photon PBI with superior organs-at-risk sparing. We report 3-year outcomes of the first prospective, multicenter, phase II tr
Externí odkaz:
https://doaj.org/article/31d00651d5fb45fda717fba1f2720675
Autor:
Mark V. Mishra, Rahul Khairnar, Søren M. Bentzen, Gary Larson, Henry Tsai, Christopher Sinesi, Carlos Vargas, George Laramore, Carl Rossi, Lane Rosen, Kai Sun, William Hartsell
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 50-54 (2020)
Background: Although pencil beam scanning (PBS) is the most conformal method for proton beam therapy (PBT) delivery, it is unknown if outcomes differ compared to treatment with passive scatter/uniform scanning (PS/US). This analysis compares patient
Externí odkaz:
https://doaj.org/article/fb5699f1503b4a6e8d256d059d7b84f7
Autor:
Jacob S. Parzen, MD, Michael D. Chuong, MD, John Chang, MD, Lane Rosen, MD, James Urbanic, MD, William Hartsell, MD, Henry Tsai, MD, Christopher Sinesi, MD, Jing Zeng, MD, Mark Mishra, MD, Carlos Vargas, MD, Craig Stevens, MD, PhD, Peyman Kabolizadeh, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100751- (2021)
Purpose: Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spare adjacent critical organs, improving toxicity profiles and potentially improving clinical outcome
Externí odkaz:
https://doaj.org/article/b81d6a59444649d8a93c4f32881d5a39
Autor:
Mark V. Mishra, Rahul Khairnar, Søren M. Bentzen, Gary Larson, Henry Tsai, Christopher Sinesi, Carlos Vargas, George Laramore, Carl Rossi, Lane Rosen, Mingyao Zhu, William Hartsell
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 19, Iss , Pp 80-86 (2019)
Background and purpose: Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted us
Externí odkaz:
https://doaj.org/article/031e37d1c1554c70a00bfe099aa11992
Autor:
Carlos E. Vargas, MD, Matthew Q. Schmidt, MD, Joshua R. Niska, MD, William F. Hartsell, MD, Sameer R. Keole, MD, Lucius Doh, MD, John Han-Chih Chang, MD, Christopher Sinesi, MD, Rossio Rodriquez, CTR, Mark Pankuch, PhD, Gary L. Larson, MD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 3, Pp 322-330 (2018)
Purpose: Randomized evidence for extreme hypofractionation in prostate cancer is lacking. We aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and extreme hypofractionated radiation in a phase 3 ran
Externí odkaz:
https://doaj.org/article/336159505966417a8be0b834023ea136
Autor:
Kai Sun, Mark V. Mishra, Lane R. Rosen, G.L. Larson, William F. Hartsell, Søren M. Bentzen, Rahul Khairnar, Carlos Vargas, C.J. Rossi, Christopher Sinesi, Henry Tsai, George E. Laramore
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss, Pp 50-54 (2020)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Data comparing PROs with pencil beam and passive scattering are lacking. • We performed a comparison of EPIC domain scores for prostate cancer patients. • Results were sensitive to the methods used to compare PROs. • Future studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8caef9fbd94939f54f8052fdeb57c920
http://www.sciencedirect.com/science/article/pii/S2405630820300161
http://www.sciencedirect.com/science/article/pii/S2405630820300161
Autor:
John Chang, William F. Hartsell, Carlos Vargas, Michael D. Chuong, Mark V. Mishra, Jacob S Parzen, James J. Urbanic, Peyman Kabolizadeh, Christopher Sinesi, Craig W. Stevens, L.R. Rosen, Jing Zeng, Henry Tsai
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100751-(2021)
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100751-(2021)
Purpose Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spare adjacent critical organs, improving toxicity profiles and potentially improving clinical outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9abeb5b0631a493899e0fc381c3bde26
https://pubmed.ncbi.nlm.nih.gov/34646969
https://pubmed.ncbi.nlm.nih.gov/34646969
Autor:
Christopher Sinesi, J. Chang, Sameer R. Keole, C.S. Thorpe, William F. Hartsell, Carlos Vargas, Patrick J. Sweeney, Todd A. DeWees, Mark V. Mishra, Vinai Gondi, Lisa A. McGee, M. Petersen, N. Mohammed, R.S. Bhangoo
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e266
Purpose/Objective(s) We present an interim analysis of toxicity and quality-of-life (QOL) from a randomized phase III trial of extreme hypofractionated versus standard hypofractionated proton therapy for low-risk prostate cancer. Materials/Methods Fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeb401dadd2ab4acc27b6e617cc7d5de
https://doi.org/10.1016/j.ijrobp.2021.07.870
https://doi.org/10.1016/j.ijrobp.2021.07.870
Autor:
William F. Hartsell, Sameer R. Keole, Vinai Gondi, M. Petersen, J.C. Rwigema, R.S. Bhangoo, Todd A. DeWees, Joe Chang, Christopher Sinesi, Carlos Vargas, C.S. Thorpe
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e295
PURPOSE/OBJECTIVE(S) To report the analysis on the quality of life (QOL) and toxicity in intermediate-risk prostate cancer patients treated with or without androgen deprivation therapy (ADT) on PCG GU 003. MATERIALS/METHODS Between 2012 and 2019, int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34a16edacb6544e5837fd2eebe0c5559
https://doi.org/10.1016/j.ijrobp.2021.07.932
https://doi.org/10.1016/j.ijrobp.2021.07.932
Autor:
C.J. Rossi, Rahul Khairnar, Mark V. Mishra, Henry Tsai, M. Zhu, L.R. Rosen, G.L. Larson, Søren M. Bentzen, Christopher Sinesi, George E. Laramore, William F. Hartsell, Carlos Vargas
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 19, Iss, Pp 80-86 (2019)
Clinical and Translational Radiation Oncology, Vol 19, Iss, Pp 80-86 (2019)
Highlights • Benefits of proton beam therapy for treatment of prostate cancer are unknown. • Data comparing pencil beam vs. passive scatter/uniform scanning protons are limited. • Significant differences in acute toxicity between proton modalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a39f4f1013f9d8a9b194aad0504130
https://pubmed.ncbi.nlm.nih.gov/31650043
https://pubmed.ncbi.nlm.nih.gov/31650043